Detalhe da pesquisa
1.
Nonclinical safety biomarkers of drug-induced vascular injury: current status and blueprint for the future.
Toxicol Pathol
; 42(4): 635-57, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24777748
2.
Frontiers in preclinical safety biomarkers: microRNAs and messenger RNAs.
Toxicol Pathol
; 41(1): 18-31, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22659243
3.
MicroRNA changes in rat mesentery and serum associated with drug-induced vascular injury.
Toxicol Appl Pharmacol
; 262(3): 310-20, 2012 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22627061
4.
Anti-tumor Activity of the Type I PRMT Inhibitor, GSK3368715, Synergizes with PRMT5 Inhibition through MTAP Loss.
Cancer Cell
; 36(1): 100-114.e25, 2019 07 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31257072
5.
Non-Lethal Endotoxin Injection: A Rat Model of Hypercoagulability.
PLoS One
; 12(1): e0169976, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28081568
6.
Preliminary comparison of quantity, quality, and microarray performance of RNA extracted from formalin-fixed, paraffin-embedded, and unfixed frozen tissue samples.
J Histochem Cytochem
; 54(11): 1229-37, 2006 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-16864893
7.
Detection and characterization of circulating endothelial progenitor cells in normal rat blood.
J Pharmacol Toxicol Methods
; 60(3): 263-74, 2009.
Artigo
em Inglês
| MEDLINE | ID: mdl-19577656
8.
Novel vascular lesions in mice given a non-peptide vitronectin receptor antagonist.
Toxicol Pathol
; 35(7): 958-71, 2007 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-18098042